Flagship of China’s ‘Godfather of Cardiovascular Surgery’ Slices Towards IPO
The maker of cardiovascular interventional medical devices has been approved for a listing on the Hong Kong Stock ExchangeKey Takeaways:OrbusNeich Medical has been approved for a Hong Kong IPO, and…
RELATED ARTICLES
-
CHINA BULLETIN: Services, Trade Send Positive Signals
- CHINA BULLETIN: Blinken, Yellen Talk Up China Challenge
-
Novel drugs lift Sino Biopharm earnings, easing price-cap pain
1177.HK
- CHINA BULLETIN: Manufacturing Déjà Vu
-
Keep Inc. sprints towards profits as investors remain wary
3650.HK
-
So-Young dolls up with pivot to high-end services
SY.US
-
Junshi hopes new scientist CEO can cure its woes
1877.HK 688180.SHG
